Guardant Health Net Profit Margin 2017-2024 | GH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Guardant Health average net profit margin for 2023 was -100.92%, a 23.67% decline from 2022.
Guardant Health average net profit margin for 2022 was -132.21%, a 15.37% decline from 2021.
Guardant Health average net profit margin for 2021 was -114.6%, a 94.37% increase from 2020.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Guardant Health average net profit margin for 2023 was -100.92%, a 23.67% decline from 2022.
Guardant Health average net profit margin for 2022 was -132.21%, a 15.37% decline from 2021.
Guardant Health average net profit margin for 2021 was -114.6%, a 94.37% increase from 2020.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$147B
Gilead Sciences (GILD)	$116B
Bristol Myers Squibb (BMY)	$115.8B
Vertex Pharmaceuticals (VRTX)	$110.2B
CSL (CSLLY)	$81.9B
Regeneron Pharmaceuticals (REGN)	$74.7B
GSK (GSK)	$69.3B
Argenex SE (ARGX)	$38.6B
Alnylam Pharmaceuticals (ALNY)	$34.4B
BioNTech SE (BNTX)	$27.6B
Illumina (ILMN)	$22.3B
BeiGene (ONC)	$21.7B
Biogen (BIIB)	$20.8B
Moderna (MRNA)	$14.8B
Insmed (INSM)	$14B
Incyte (INCY)	$13.9B
Genmab (GMAB)	$13.9B
Genmab (GNMSF)	$13.9B
Intra-Cellular Therapies (ITCI)	$13.5B
Bio-Techne Corp (TECH)	$12.5B
BioMarin Pharmaceutical (BMRN)	$11.8B
Sarepta Therapeutics (SRPT)	$11.1B
Vaxcyte (PCVX)	$10.8B
QIAGEN (QGEN)	$10.8B
Exact Sciences (EXAS)	$10.1B
Swedish Orphan Biovitrum (BIOVF)	$10.1B
Bio-Rad Laboratories (BIO.B)	$9.8B
Exelixis (EXEL)	$9.4B
Repligen (RGEN)	$9.3B
Roivant Sciences (ROIV)	$8.1B